Haemonetics Corp (HAE)
84.08
-0.57
(-0.67%)
USD |
NYSE |
May 31, 16:00
84.14
+0.06
(+0.07%)
After-Hours: 20:00
Haemonetics Cash from Investing (Quarterly): -13.06M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -13.06M |
December 31, 2023 | -268.94M |
September 30, 2023 | -25.14M |
June 30, 2023 | -15.26M |
March 31, 2023 | -18.01M |
December 31, 2022 | -36.50M |
September 30, 2022 | -31.07M |
June 30, 2022 | -58.21M |
March 31, 2022 | -34.51M |
December 31, 2021 | -15.46M |
September 30, 2021 | -20.52M |
June 30, 2021 | -15.85M |
March 31, 2021 | -429.10M |
December 31, 2020 | -9.581M |
September 30, 2020 | 37.14M |
June 30, 2020 | -23.90M |
March 31, 2020 | -45.14M |
December 31, 2019 | -19.87M |
September 30, 2019 | 5.964M |
June 30, 2019 | 1.861M |
March 31, 2019 | -13.22M |
December 31, 2018 | -27.58M |
September 30, 2018 | -48.08M |
June 30, 2018 | -27.26M |
March 31, 2018 | -17.97M |
Date | Value |
---|---|
December 31, 2017 | -26.29M |
September 30, 2017 | -15.04M |
June 30, 2017 | -3.74M |
March 31, 2017 | -14.57M |
December 31, 2016 | -17.32M |
September 30, 2016 | -19.04M |
June 30, 2016 | -22.39M |
March 31, 2016 | -28.29M |
December 31, 2015 | -23.64M |
September 30, 2015 | -25.71M |
June 30, 2015 | -27.13M |
March 31, 2015 | -21.62M |
December 31, 2014 | -29.65M |
September 30, 2014 | -33.47M |
June 30, 2014 | -37.02M |
March 31, 2014 | -30.81M |
December 31, 2013 | -15.63M |
September 30, 2013 | -23.74M |
June 30, 2013 | -35.65M |
March 31, 2013 | -11.86M |
December 31, 2012 | -14.32M |
September 30, 2012 | -561.03M |
June 30, 2012 | -9.189M |
March 31, 2012 | -15.75M |
December 31, 2011 | -12.73M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-429.10M
Minimum
Mar 2021
37.14M
Maximum
Sep 2020
-51.76M
Average
-20.19M
Median
Cash from Investing (Quarterly) Benchmarks
ResMed Inc | -33.15M |
Stryker Corp | -408.00M |
Boston Scientific Corp | -285.00M |
InfuSystems Holdings Inc | -0.418M |
Perspective Therapeutics Inc | -47.30M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 64.08M |
Cash from Financing (Quarterly) | -63.50M |
Free Cash Flow | 115.46M |
Free Cash Flow Per Share (Quarterly) | 1.058 |
Free Cash Flow to Equity (Quarterly) | 117.19M |
Free Cash Flow to Firm (Quarterly) | 60.08M |
Free Cash Flow Yield | 2.67% |